“METASTATIC COLORECTAL CANCER MCRC WITH WILD-TYPE RAS: THE CONTINUATION OF ANTI-EGFR THERAPY WITH A CHANGE OF CHEMOTHERAPY AFTER DISEASE PROGRESSION”. Voprosy Onkologii, vol. 63, no. 3, Mar. 2017, pp. 456-60, https://doi.org/10.37469/0507-3758-2017-63-3-456-460.